Journal of Clinical Virology
Volume 46, Supplement 4 , Pages S64-S67, December 2009

CMV vaccine trial endpoints

  • P.D. Griffiths

      Affiliations

    • Corresponding Author InformationTel.: +44 020 7830 2997; fax: +44 020 7830 2854.

Centre for Virology, University College London Medical School, Rowland Hill Street, London NW3 2PF, United Kingdom

Received 7 May 2009; received in revised form 5 October 2009; accepted 6 October 2009. published online 02 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1386-6532(09)00493-4

doi:10.1016/j.jcv.2009.10.003

Journal of Clinical Virology
Volume 46, Supplement 4 , Pages S64-S67, December 2009

Article Tools

* Image Usage & Resolution